Clinical implications for the use of a biomarker for subclinical rejection – Conflating arguments cause a disconnection between the premise and the conclusion

John Friedewald*, Michael Abecassis

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical implications for the use of a biomarker for subclinical rejection – Conflating arguments cause a disconnection between the premise and the conclusion'. Together they form a unique fingerprint.